Max Planck Society - eDoc Server

HER3 is a determinant for poor prognosis in melanoma
Authors: Reschke, M.; Mihic-Probst, D.; van der Horst, E. H.; Knyazev, P.; Wild, P. J.; Hutterer, M.; Meyer, S.; Dummer, R.; Moch, H.; Ullrich, A.
Date of Publication (YYYY-MM-DD): 2008-08-15
Title of Journal: Clinical Cancer Research
Volume: 14
Issue / Number: 16
Start Page: 5188
End Page: 5197
Document Type: Article
ID: 377513.0